Yu Nakagama

Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M

Hajime Abe, Norihiko Takeda, Takayuki Isagawa et al. · Nature Communications · 2019 · 146 citations · Full text

Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

Takashi Yoshiyama, Yasuki Saito, Kunitsugu Masuda et al. · Emerging infectious diseases · 2021 · 37 citations · Full text

Vaccination, Viral Diagnostics, Emerging Infectious Diseases +10

Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan

Tomoya Tsuchida, Naohito Yoshimura, Kosuke Ishizuka et al. · Clinical and Experimental Medicine · 2023 · 35 citations · Full text

Background Factors, Long Covid, Virus Epidemiology +8

Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies

Yu Nakagama, Yuko Komase, Natsuko Kaku et al. · Microbiology Spectrum · 2022 · 33 citations · Full text

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity

Yu Nakagama, Katherine Candray, Natsuko Kaku et al. · The Journal of Infectious Diseases · 2022 · 29 citations · Full text